Table of Contents Table of Contents
Previous Page  36 / 88 Next Page
Information
Show Menu
Previous Page 36 / 88 Next Page
Page Background

36

Scientific Programme /

Monday, 19 June 2017

WFSBP 2017

MON

004

sLORETA derived from REM sleep EEG as bio-

markers for treatment response in depression after

antidepressant medication

Marcel Pawlowski, Germany

T11: DEPRESSION: BASIC/ CLINICAL

WS-04

WORKSHOP

15:00–16:30

B3 M1-M2

Rethinking depression in the Century XXI: Where are

we now in biological psychiatry?

Chair:

Victoria Valdez, Ecuador

Co-Chair: Adriana Rivetti, Argentina

001

Genetics risk variants for major depressive disorder

Alejo Corrales, Argentina

002

Serotonergic hypothesis of depression: Is still

up-to-date?

Adriana Rivetti, Argentina

T22: MOLECULAR NEUROBIOLOGY

TFS-03

WFSBP TASK FORCE SYMPOSIUM

17:00–18:30

Congress Hall A 3

Update biomarkers in psychiatry

Chair:

Peter Riederer, Germany

Co-Chair: Peter Falkai, Germany

001

Biomarkers for schizophrenia

Florence Thibaut, France

002

Biological marker in alcoholism

Toshikazu Saito, Japan

003

Specifity of biomarkers for OCD/ADHD

Edna Grünblatt, Switzerland

004

Specifity of biomarkers for anxiety

Borwin Bandelow, Germany

T7: CHILDHOOD & ADOLESCENT DISORDERS:

BASIC/ CLINICAL

S-29

SYMPOSIUM

17:00–18:30

Auditorium 12

Autism spectrum disorders in adults – from the clinical

phenotype to the underlying neurobiology – novell

technics such as phenotype-based genetic variants

association studies, high field magnet resonance

imaging and 3d brain organoids

Chair:

Tanja Michel, Denmark

Co-Chair: Sophia Frangou, USA

001

On the outcome, time course and clinical pre-

sentation of autism in adults: A longitudinal study of

clinical trajectories

Marlene Briciet Lauritsen, Denmark

002

Accumulated common variants in the broader

fragile X gene family modulate autistic phenotypes

Hannelore Ehrenreich, Germany

003

New insights from proteomics and nanotechnol-

ogy- 3 D brain organoids: A promising new tool for an

vitro model for ASD

Tanja Michel, Denmark

004

The role of myelination in neurodevelopmental

disorders

Sophia Frangou, USA

FC-04

FREE COMMUNICATION SESSION

17:00–18:30

B3 M1-M2

Neuroimaging 1

Chair:

Glenda MacQueen, Canada

Co-Chair: Andreas J. Fallgatter, Germany

001

Cortical excitability in a healthy human cohort of

mutation carriers in Plasticity Related Gene 1

Johann-Philipp Horstmann, Germany

S. Groppa, M. Muthuraman, A. Stroh, R. Nitsch, K. Lieb,

H. J. Grabe, M. Lotze, J. Vogt, O. Tuescher

002

Near-infrared Sprectoscopy (NIRS) neurofeedback

in ADHD

Andreas J. Fallgatter, Germany

B. Barth, J. Hudak, A.-C. Ehlis

003

Child maltreatment is associated with altered

NAA/Cr concentration at the anterior cingulate gyrus

in children and adolescents

Andrea Parolin Jackowski, Brazil

A. C. Milani, B. Foester, M. Feijó de Mello